Related Experiment Videos
Contraception for women with health problems
1Department of Obstetrics and Gynecology, Thomas Jefferson University School of Medicine, Philadelphia, USA.
International Journal of Fertility and Menopausal Studies
|March 1, 1996
Summary
Clinical trials for new contraceptives exclude patients with common conditions like obesity and hypertension. This article explores real-world contraceptive counseling for these excluded patient populations.
Area of Science:
- Reproductive Medicine
- Clinical Pharmacology
Background:
- Clinical trials for novel contraceptive agents often exclude individuals with common comorbidities.
- Exclusion criteria typically screen out patients with obesity, hypertension, altered glucose metabolism, and endocrine disorders.
Purpose of the Study:
- To examine the clinical practice of contraceptive counseling for patients excluded from investigational trials.
- To address the gap between controlled trial populations and diverse real-world patient demographics.
Main Methods:
- Review of clinical scenarios involving contraceptive counseling for patients with excluded conditions.
- Analysis of challenges and considerations in providing effective contraception to these populations.
Main Results:
- Contraceptive counseling in real-world practice must accommodate patients with comorbidities often excluded from trials.
- Specific clinical pathologies necessitate tailored approaches to ensure safe and effective contraceptive use.
Conclusions:
- Bridging the gap between trial data and clinical practice is crucial for comprehensive patient care.
- Healthcare providers must be prepared to manage contraceptive needs in patients with obesity, hypertension, and metabolic or endocrine disorders.